AzTrials
AzTrials

Carbohydrate MetabolismCARBNCT06053294

Neural and Metabolic Factors in Carbohydrate Reward

A study testing CS- Beverage, CS+Fast and CS+Slow in people with Carbohydrate Metabolism, run by Virginia Polytechnic Institute and State University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Dietary factors contributed to nearly 50% of all cardiometabolic deaths in the US in 2012, making it one of the leading causes of preventable death in the US, second only to tobacco use. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Carbohydrate Metabolism
What is being tested?
CS- Beverage, CS+Fast and CS+Slow
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteUnited States
Study dates
1 May 2023to 1 May 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • BMI between 18.5-30 kg/m2
  • Not pregnant or planning to become pregnant during study participation
  • Residing in the Roanoke area and/or willing/able to attend sessions at the Fralin Biomedical Research Institute
  • Able to speak and write in English

Who cannot join

  • Current inhaled nicotine use
  • History of alcohol dependence.
  • Current or past diagnosis of diabetes or thyroid problems.
  • Taking medications known to influence study measures (including antiglycemic agents, thyroid medications, sleep medications)
  • Active medical or neurologic disorder.
  • Current shift work (typical pattern of work/activity overnight)
Show all 12Show fewer
  • Previous weight loss surgery
  • Adherence to a special diet within the past 3 months (e.g., low-carb or ketogenic diet, exclusion of food groups/specific macronutrients, intermittent fasting, etc.)
  • Allergy to any food or ingredient included in the study diets, meals, or beverages
  • Currently pregnant or planning to become pregnant during study participation
  • Claustrophobia
  • Contraindications for MRI, including pacemaker, aneurysm clips, neurostimulators, cochlear or other implants, metal in eyes, regular work with steel, etc.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Alexandra G DiFeliceantonio, PhD contact

5405262285

dife@vt.edu

United States1 site, 1 recruiting
  • Fralin Biomedical Research Institute at VTC

    Roanoke, Virginia, 24016

    Alexandra G DiFeliceantonio, PhD, 540-526-2285, dife@vt.edu

    Recruiting

Other trials in United States

About this study

Official title: Neural and Metabolic Factors in Carbohydrate Reward: An Examination of Speed

Dietary factors contributed to nearly 50% of all cardiometabolic deaths in the US in 2012, making it one of the leading causes of preventable death in the US, second only to tobacco use. Human diets and food choices can't help but be influenced by the ubiquitous availability of processed foods of high-energy density and low nutrient content, consumption of which can lead to obesity, type II diabetes, heart disease, and other types of metabolic dysfunction. Surprisingly, food reinforcement does not rely on perceived energy density. Rather food reinforcement is associated with actual energy density and therefore, on an implicit knowledge of caloric content. That implicit knowledge must have a neural signature and a mechanism by which the gut communicates nutritive value to the brain. There is evidence, at least for fat and carbohydrates, that these pathways are separable, but terminate in a common neural structure, the dorsal striatum or caudate. This could be one mechanism by which modern processed foods high in both fat and carbohydrate are so sought after and readily consumed, In fact, when experimentally tested, fat and carbohydrate combinations were more reinforcing calorie for calorie than fat or carbohydrates alone and the level of reinforcement correlated with activity in reward- related brain areas. Beyond simple reinforcing value, it is known from the literature on drugs of abuse that the faster a drug is arrives at the brain, the higher it's abuse potential, however, little is known about how the kinetics of nutrient excursion influence food preference, choice, and brain activity. This project aims to test this specifically for carbohydrate reward.

Being tested
CS- Beverage, CS+Fast, CS+Slow

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CS- BeverageOther

    Conditioned Stimulus - (CS-): Flavored beverage solution with sweetness-matched sucralose. Participants will consume flavored beverage solutions sweetened with sucralose to match the sweetness of 110 calories of sucrose in 6 exposure sessions within 1 week. One exposure session will include pre- and post-consumption blood draws and indirect calorimetry measurement over a 2-hour period. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.

  • CS+FastOther

    (CS+): Flavored beverage solution with 110 calories of sucrose. Participants will consume flavored beverage solutions containing 110 calories of sucrose in 6 exposure sessions within 1 week. One exposure session will include pre- and post-consumption blood draws and indirect calorimetry measurement over a 2-hour period. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.

  • CS+SlowOther

    (CS+): Flavored beverage solution with 110 calories of maltodextrin. Participants will consume flavored beverage solutions containing 110 calories of maltodexrin in 6 exposure sessions within 1 week.One exposure session will include pre- and post-consumption blood draws and indirect calorimetry measurement over a 2-hour period. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.

Study groups in NCT06053294
Study groupRoleWhat they receive
CS- FirstExperimentalParticipants who receive the conditional stimulus (CS) - first.
Receives: Other: CS- Beverage; Other: CS+Fast; Other: CS+Slow
CS+Fast FirstExperimentalParticipants who receive the CS+Fast First
Receives: Other: CS- Beverage; Other: CS+Fast; Other: CS+Slow
CS+Slow FirstExperimentalParticipants who receive the CS+Slow First
Receives: Other: CS- Beverage; Other: CS+Fast; Other: CS+Slow

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in preference- liking

    Subjective ratings of liking of flavors used in the intervention will be assessed at baseline and after the intervention.

    The generalized Labeled Magnitude Scale will be used. The scale is anchored by descriptors of "Most Disliked Sensation Imaginable" and "Most Liked Sensation Imaginable" at the lower and upper ends, respectively. The score is determined by the place on the scale participants select (range of scale is 0-100). An increase in score from baseline to post-intervention indicates an increase in liking.

    Measured: at the end of the study; 5 weeks after start of study

Secondary outcomes (9)
  1. Change in preference- wanting, rated

    Subjective ratings of wanting of flavors used in the intervention will be assessed at baseline and after the intervention. A Visual Analog Scale will be used. Participants select a place on the line that corresponds with their subjective rating, and the score is determined by the place selected (range of scores is 0-100). The line is anchored by polar opposite descriptors ("Do not want at all" and "Want very much"). An increase in score from baseline to post-intervention indicates and increase in wanting.

    Measured: at the end of the study; 5 weeks after start of study

  2. Change in preference- wanting, ad lib intake

    Ad libitum intake will be used as a measure of wanting in a post-test session. Participants will be provided each beverage used during the intervention and asked to drink as much or as little of them as they would like over a 30- minute period.

    Measured: at the end of the study; 5 weeks after start of study

  3. Change in preference- wanting, forced choice

    Forced choice will be used as a measure of wanting in a post-test session. Participants will be provided each of the beverages used during the intervention and asked to choose 1 to take home with them.

    Measured: at the end of the study; 5 weeks after start of study

  4. Blood oxygen level-dependent (BOLD) response to beverages

    In a post-test session, functional magnetic resonance imaging (fMRI) scans will be performed while beverages (without calories) used during the intervention are delivered through a custom manifold fitted to a head coil and connected to a pump system that allows precisely timed and measured delivery of liquids.

    Measured: at the end of the study; 5 weeks after start of study

  5. Blood glucose response to beverages

    Blood glucose will be assessed at baseline and at set time points for 1 hour after consumption of intervention beverages in one exposure session.

    Measured: Each week for 3 weeks during the study

  6. Blood insulin response to beverages

    Blood insulin will be assessed at baseline and at set time points for 2 hours after consumption of intervention beverages in an exposure session.

    Measured: Each week for 3 weeks during the study

  7. Energy expenditure in response to beverages

    Indirect calorimetry will be used to determine energy expenditure at baseline (for 30 minutes) and for 1 hour after consumption of intervention beverages in an exposure session.

    Measured: Each week for 3 weeks during the study

  8. Respiratory exchange ratio in response to beverages

    Indirect calorimetry will be used to determine respiratory exchange ratio at baseline (for 30 minutes) and for 1 hour after consumption of intervention beverages in an exposure session.

    Measured: Each week for 3 weeks during the study

  9. Substrate oxidation in response to beverages

    Indirect calorimetry will be used to determine substrate oxidation at baseline (for 30 minutes) and for 1 hour after consumption of intervention beverages in an exposure session.

    Measured: Each week for 3 weeks during the study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Sep 2023
  2. Study start1 May 2023
  3. Primary completion1 May 2028 (estimated)
  4. Study completion1 May 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
64 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06053294
Sponsor's protocol ID
19-927
Acronym
CARB
Status last verified
Jun 2026
First submitted
24 Aug 2023
Last updated
2 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Kelly AL, Baugh ME, Ahrens ML, Valle AN, Sullivan RM, Oster ME, Fowler ME, Carter BE, Davy BM, Hanlon AL, DiFeliceantonio AG. Neural and metabolic factors in carbohydrate reward: Rationale, design, and methods for a flavor-nutrient learning paradigm in humans. Contemp Clin Trials. 2024 Dec;147:107717. doi: 10.1016/j.cct.2024.107717. Epub 2024 Oct 15.

    PubMed 39413990

Questions about this trial

What is this clinical trial studying?

A study testing CS- Beverage, CS+Fast and CS+Slow in people with Carbohydrate Metabolism, run by Virginia Polytechnic Institute and State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Alexandra G DiFeliceantonio, PhD (5405262285, dife@vt.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in preference- liking (time frame: at the end of the study; 5 weeks after start of study). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06053294, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in